Retatrutide, a experimental dual stimulator of the GLP-1 binding site and glucose-dependent insulinotropic polypeptide (GIP) receptor , is showing promising results in initial human trials . Ongoing https://freshbookmarking.com/story21375351/retatrutide-emerging-investigations-and-possible-medical-applications